HIVClinicalForum
Meeting category
Date(s)
22 Jul 2017 - 22 Jul 2016
Location
Paris, France
Organizer

Global HIV Clinical Forum 2017

Related Enduring Materials

Enduring Materials
Session 1: Basic Principles -
Basic Science of Integrase Inhibitors - Recent Advances
Francois Clavel
Francois Clavel, MD
Hôpital Saint-Louis, Paris, France
Resistance Characteristics of Integrase Inhibitors
Charlotte Charpentier
Charlotte Charpentier, PharmD, PhD
Hôpital Bichat-Claude Bernard, Paris, France
Clinical Case - Transmitted/Acquired Resistance Related
Michelle Moorhouse
Michelle Moorhouse, MBBCh
Wits RHI, Johannesburg, South Africa
Session 2: Pharmacology and Global Implementation -
Potential role of Integrase Inhibitors in resource-limited settings
Gary Maartens
Gary Maartens, MD
University of Cape Town, Cape Town, South Africa
Clinical Pharmacology related considerations
David Back, PhD
University of Liverpool, United Kingdom
Session 3: Challenging Populations -
Optimal Use of Integrase Inhibitors in Women
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Pediatric use of Integrase Inhibitors
Mark Cotton, MD, PhD
Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU), South Africa
Abstract Presentations -
Clinical case of transmitted resistance to HIV Integrase Inhibitors
Dr. Carmen María González Domenech
Spain
Mutations to Integrase inhibitors in real life
Dr. Isabel Viciana Ramos
Spain
Dolutegravir monotherapy in HIV-infected naive patients with <100,000 copies/ml HIV-RNA load: a long-term follow-up
Dr. Massimiliano Lanzafame
Italy
Session 4: Clinical Utility of Integrase Inhibitors -
The Role of Integrase Inhibitors during HIV prevention
Pep Coll, MD
AIDS Research Institute-IrsiCaixa, Spain
Clinical Case -Reduced Drug Regimen
Pedro Cahn, MD, PhD
Fundación Huésped Buenos Aires, Argentina
Optimizing Clinical Utility of Integrase Inhibitors
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
Overview

The second edition of the Global HIV Clinical Forum on Integrase Inhibitors was held on 22 July, 2017 in Paris (France), preceding the IAS2017.

The meeting was an incredible success with almost 85 attendees visiting the meeting!

The Global HIV Clinical Forum focused entirely on Integrase Inhibitors as Integrase Inhibitors are rapidly gaining a central role in the routine care of HIV infected individuals. The HIV Clinical Forum meetings aim at enhancing the clinical skills and research capabilities of HIV healthcare professionals in regard to this unique class of antiretroviral drugs.

On behalf of the Global HIV Clinical Forum Program Chairs, we would like to thank ViiV Healthcare for their unrestricted education grant, as well as Mylan for their generous contribution. We would also like to thank our endorsers for their invaluable support of the meeting and of course a big thank you to all of our participants in making this meeting into a huge success!

Program Chairs

General Information 

Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients

- Create a platform for interactive information exchange on novel treatment options

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies

- Describe the pros and cons of novel treatment strategies

- Understand how to integrate novel treatment strategies into routine patient care

- Be knowledgeable of the clinical data supporting long-acting injectable regimens

- Identify patients who might best benefit from long acting injectable regimens

- Know how best to integrate injectable drugs in to routine clinical care

- Improve their skills in defining and identifying complex HIV patients

- Stay informed on new drug options for complex patients

- Understand how best to use new treatment options in complex HIV patients

Practical Information 

Disclaimer
This forum is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this forum. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the forum.